Selenium and its relationship to cancer: An update

British Journal of Nutrition

Volumn 91, Issue 1, 2004, Pages 11-28

  Whanger, Phil D ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Cancer; Selenium

Indexed keywords

1,4 PHENYLENE DIMETHYLENESELENOCYANATE; ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; ASCORBIC ACID; BENZYL SELENOCYANATE; BETA CAROTENE; BIOLOGICAL MARKER; CARCINOGEN; METHYLSELENINIC ACID; NICOTINIC ACID; PLACEBO; RETINOL; RIBOFLAVIN; SELENITE; SELENIUM; SELENIUM DERIVATIVE; SELENOCYSTEINE; SELENOENZYME; SELENOMETHIONINE; SELENOPROTEIN; SODIUM SELENITE; TRIPHENYLSELENONIUM BROMIDE; UNCLASSIFIED DRUG; ZINC;

APOPTOSIS; BREAST TUMOR; BROCCOLI; CANCER; CANCER INCIDENCE; CANCER THERAPY; CEREAL; CLINICAL TRIAL; COLON TUMOR; DIET SUPPLEMENTATION; DNA REPAIR; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELEMENTAL DIET; EPIDEMIOLOGICAL DATA; ESOPHAGUS CANCER; FOOD INTAKE; GARLIC; HAIR LOSS; HUMAN; LIVER CANCER; NAIL DISEASE; NONHUMAN; REVIEW; SKIN TUMOR; STOMACH CANCER; TUMOR IMMUNITY; VITAMIN SUPPLEMENTATION; YEAST;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOGENS; CULTURE TECHNIQUES; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY; INCIDENCE; NECROSIS; NEOPLASMS; PLANTS; SELENIUM; SELENIUM COMPOUNDS;

ALLIUM SATIVUM; ANIMALIA; BRASSICA OLERACEA VAR. BOTRYTIS;

EID: 0346707259     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20031015     Document Type: Review

References (174)

1. American Cancer Society (2000) Cancer Facts and Figures. Atlanta, GA: American Cancer Society.
2. Behne D, Kyriakopoulos A, Kalchlosch M, et al. (1997) Two new selenoproteins found in the prostatic glandular epithelium and in the spermatid nuclei. Biomed Environ Sci 10, 340-345.
3. Beilstein MA & Whanger PD (1986) Chemical forms of selenium in rat tissues after administration of selenite or selenomethionine. J Nutr 116, 1711-1719.
4. Beilstein MA & Whanger PD (1988) Glutathione peroxidase activity and chemical forms of selenium in tissues of rats given selenite or selenomethionine. J Inorgan Biochem 33, 31-46.
5. Beilstein MA, Whanger PD & Yang GQ (1991) Chemical forms of selenium in corn and rice grown in a high selenium area of China. Biomed Environ Sci 4, 392-398.
6. Blot WJ (1997) Vitamin/mineral supplementation and cancer risk: International chemoprevention trials. PSEBM 216, 291-296.
7. Blot WJ, Li J-Y, Taylor JR, et al. (1993) Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Nat Cancer Inst 85, 1483-1490.
8. Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey SM & Li B (1995) Linxian trials: Mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 62, 1424S-1426S.
9. Bonelli L, Camoriano A, Ravelli P, Missale G, Bruzzi P & Aste H (1998) Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. In Proceedings of International Selenium Tellurium Development Association, pp. 91-94 [Y Palmieri, editor]. Brussels, Belgium: Se-Te Press.
10. Brooks JD, Metter BEJ, Chan DW, et al. (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166, 2034-2038.
11. Brown T & Shrift A (1981) Exclusion of selenium from proteins of selenium-tolerant Astragalus species. Plant Physiol 67, 1051-1059.
12. Burke KE, Burford RG, Combs GF, French IW & Skeffington DR (1992a) The effect of topical L-selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. Photodermatol Photoimmunol Photomed 9, 52-57.
13. Burke KE, Combs GF, Gross EG, Bhuyan KC & Abu-Libdeh H (1992b) The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation. Nutr Cancer 17, 123-137.
14. Burnell JN & Shrift A (1977) Cysteinyl-tRNA synthetase from Phaseolus aureus. Purification and properties. Plant Physiol 60, 670-678.
15. Cai X-J, Block E, Uden PC, Zhang X, Quimby BD & Sullivan JJ (1995) Allium chemistry: Identification of selenoamino acids in ordinary and selenium-enriched garlic, onion and broccoli using gas chromatography with atomic emission detection. J Agric Food Chem 43, 1754-1757.
16. Chen DM, Nigam SN & McConnell WB (1970) Biosynthesis of Se-methylselenocysteine and S-methylcysteine in Astragalus bisulcatus. Can J Biochem 48, 1278-1284.
17. Chen J, Goetchius MP, Campbell TC & Combs GF (1982a) Effects of dietary selenium and vitamin E on hepatic mixed-function oxidase activities and in vivo covalent binding of aflatoxin B1 in rats. J Nutr 112, 324-349.
18. Chen J, Goetchius MP, Combs GF & Campbell TC (1982b) Effects of dietary selenium and vitamin E on covalent binding of aflatoxin to chick liver cell macromolecules. J Nutr 112, 350-355.
19. Chow CK & Gairola GC (1984) Influence of dietary vitamin E and selenium on metabolic activation of chemicals to mutagens. J Agric Food Chem 32, 43-447.
20. Clark LC, Cantor KP & Allaway WH (1981) Selenium in forage crops and cancer mortality in U.S. countries. Arch Environ Health 46, 37-42.
21. Clark LC, Combs GF, Turnbull BW, et al. (1996) The nutritional prevention of cancer with selenium 1983-1993; A randomized clinical trial. J Am Med Assoc 276, 1957-1963.
22. Clark LC, Dalkin B, Krongrad A, Combs GF & Turnbull W (1998) Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81, 730-734.
23. Clark L, Hixson LJ, Combs GF, Reid ME, Turnabull BW & Sampliner RE (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers 2, 41-46.
24. Clayton CC & Bauman CA (1949) Diet and azo dye tumors: Effect of diet during a period when the dye is not fed. Cancer Res 9, 575-580.
25. Coates RJ, Weiss NS, Daling JR, Morris JS & Labbe RF (1988) Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128, 515-523.
26. Cohen LA (editor) (2001) Larry Clark, in memoriam. In Nutr Cancer, 40, 1-77.
27. Combs GF Jr (2001). Selenium in global food systems. Br J Nutr 85, 517-547.
28. Combs GF & Combs SB (1986a). Chemical aspects of selenium. In The Role of Selenium in Nutrition, chapter 1 pp. 1-8. San Diego, CA: Academic Press.
29. Combs GF & Combs SB (1986b). Selenium and cancer. In The Role of Selenium in Nutrition, chapter 10, pp. 413-462, San Diego, CA: Academic Press.
30. Combs GF & Gray WP (1998). Chemopreventive agents: Selenium. Pharmacol Ther 79, 179-192.
31. Davis C, Zeng H & Finley JW (2002). Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr 132, 307-309.
32. Davis CD, Fengn Y, Hein DW & Finley JW (1999). The chemical form of selenium influences 3, 2′-dimethyl-4-amino-biphenyl-DNA adduct formation in rat colon. J Nutr 29, 63-69.
33. Diamond AM, Hu YJ & Mansur DB (2001). Glutathione peroxidase and viral replications: Implications for viral evolution and chemoprevention. Biofactors 14, 205-210.
34. Donadlson WE (1977). Selenium inhibition of avian fatty acid synthase complex. Chem Biol Interact 17, 313-320.
35. Dong L, Wang W, Wang F, Stoner M & Reed JC (1999). Mechanism of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J Biol Chem 274, 32099-32107.
36. Dong Y, Lisk DJ, Block E & Ip C (2001). Characterization of the biological activity of γ-glutamyl-Se-methylselenocysteine: A novel, naturally occurring anticancer agent from garlic. Cancer Res 61, 2923-2928.
37. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11, 630-639.
38. El-Bayoumy K (1985). Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res 45, 3631-3635.
39. El-Bayoumy K (2001). The protective role of selenium on genetic damage and on cancer. Mutat Res 475, 123-139.
40. El-Bayoumy K, Chen YH, Upadhyaya P, Mescher C, Cohen LA & Reddy BS (1992). Selenium in chemoprevention of carcinogenesis II. Inhibition of 7,12-dimethylbenz(a)-anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organo-selenium compound 1,4-phenylenebis-(methylene) selenocyanate. Cancer Res 52, 2402-2407.
41. Feng Y, Finley JW, Davis CD, Becker WK, Fretland AJ & Hein DW (1999). Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2′-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 157, 36-42.
42. Fiala ES, Joseph C, Sohn OS, El-Bayoumy K & Reddy BS (1991). Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 54, 2826-2830.
43. Finley JW & Davis CD (2001). Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 14, 191-196.
44. Finley JW, Davis C & Feng Y (2000). Selenium from high-selenium broccoli is protective against colon cancer in rats. J Nutr 130, 2384-2389.
45. Finley JW, Ip C, Lisk DJ, Davis CD, Hintze K & Whanger PD (2001). Investigations on the cancer protective properties of high selenium broccoli. J Agric Food Chem 49, 2679-2683.
46. Fleming J, Ghose A & Harrison PR (2001). Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 40, 42-49.
47. Good and Agriculture Organization/World Health Organization (2002) Human Vitamin and Mineral Requirements. Report of a Joint FAO/WHO Expert Consultation. Bangkok: FAO/WHO.
48. Food and Nutrition Board, Institute of Medicine (2000) Selenium. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids, pp. 284-324. Washington, DC: National Academy Press.
49. Foster HD (2002) What Really Causes AIDS, pp. 198. Victoria, BC: Trafford Publishing Co.
50. Galter D, Mihm S & Droge W (1994). Distinct effect of glutathione disulfide on the nuclear transcription factor κB and the activator protein-1. Eur J Biochem 221, 639-648.
51. Ganther HE (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 20, 1657-1666.
52. Ganther HE & Corcoran C (1969) Selenotrisulfides II. Cross-linking of reduced pancreatic ribonuclease with selenium. Biochemistry 8, 2557-2563.
53. Ganther HE & Ip C (2001) Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr 131, 301-304.
54. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, et al. (1995) Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87, 497-505.
55. Ghose A, Fleming J, El-Bayoumy K & Harrison PR (2001) Enhance sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: Involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 61, 7479-7487.
56. Gladyshev VN (2001) Identity, evolution and function of selenoproteins and selenoprotein genes. In Selenium: Its Molecular Biology and Role in Human Health, pp. 99-114 [DL Hatfield, editor]. Boston, MA: Kluwer Academic Publishers.
57. Gladyshev VN, Stadtman TC, Hatfield DL & Jeang KT (1999) Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc Natl Acad Sci 96, 835-839.
58. Glattre EY, Thomassen SO, Thoresen T, Haldorsen PG & Lund-Larsen PG (1989) Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 18, 45-49.
59. Gopalakrishna R & Gundimeda U (2002a) Protein kinase C as a molecular target for cancer prevention by selenocompounds. Nutr Cancer 40, 55-63.
60. Gopalakrishna R & Gundimeda U (2002b) Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 132, 3819S-3823S.
61. Guo W-D, Hsing AW, Li JY, Chen J-S, Chow W-H & Blot WJ (1994) Correlation of cervical cancer mortality with reproductive and dietary factors, and serum markers in China. Int J Epidemiol 23, 1127-1132.
62. Harrison PR, Lanfear J, Wu L, Fleming J & Blower L (1996) Mechanisms of chemoprevention and growth inhibition by selenium compounds. In Proceedings of the 6th International Symposium on Selenium in Biology and Medicine, pp. 74-82. New York, NY: Van Nostrand Reinhold.
63. Helzlsouer KJ, Comstock WG & Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol and subsequent bladder cancer. Cancer Res 49, 6144-6148.
64. Holmgren A (2001) Selenoproteins of the thioredoxin system. In Selenium: Its Molecular Biology and Role in Human Health, pp. 179-189 [DL Hatfield, editor]. Boston, MA: Kluwer Academic Publishers.
65. Horvath PM & Ip C (1983) Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Res 43, 5335-5341.
66. Hu YJ, Korothov KV, Mehta R, et al. (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3′ untranslated region of the human Sep 15 gene. Cancer Res 61, 2307-2310.
67. Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE & Willet WC (1990) A prospective study of selenium status and breast cancer risk. J Am Med Assoc 264, 1128-1131.
68. Imam SZ & Ali SF (2000) Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 855, 186-191.
69. Ip C (1988) Differential effects of dietary methionine on the biopotency of selenomethionine and selenite in cancer chemoprevention. J Natl Cancer Inst 80, 258-262.
70. Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845-1854.
71. Ip C, Birringer M, Block E, et al. (200a) Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 48, 2062-2070.
72. Ip C & Dong Y (2001) Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res 21, 863-867.
73. Ip C, El-Bayoumy K, Upadhyaya P, Ganther HE, Vadhanavikit S & Thompson H (1994a) Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis 15, 187-192.
74. Ip C & Ganther HE (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res 50, 1206-1311.
75. Ip C & Ganther HE (1992a) Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13, 1167-1170.
76. Ip C & Ganther HE (1992b) Biological activities of trimethylselenonium as influenced by arsenite. J Inorg Biochem 46, 215-222.
77. Ip C & Ganther HE (1993) Novel strategies in selenium cancer chemoprevention research. In Selenium in Biology and Human Health, pp. 170-180 [RF Burk, editor]. New York: Springer-Verlag, New York.
78. Ip C & Lisk DJ (1994) Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. Carcinogenesis 15, 573-576.
79. Ip C, Lisk DJ & Stoewsand GS (1992) Mammary cancer prevention by regular garlic and selenium-enriched garlic. Nutr Cancer 17, 279-286.
80. Ip C & Medina D (1987) Current concepts of selenium and mammary tumorigenesis. In Cellular and Molecular Biology of Breast Cancer, pp. 479-494 [D Medina, W Kidwell, G Heppner and EP Anderson, editors]. New York: Plenum Press.
81. Ip C, Thompson HJ & Ganther HE (1994b) Activity of triphenyl-selenonium chloride in mammary cancer prevention. Carcinogenesis 15, 2879-2882.
82. Ip C, Thompson HJ, Zhu Z & Ganther HE (2000b) In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res 60, 2882-2886.
83. Jacobs MM, Matney JA & Griffin AC (1977) Inhibitory effects of selenium on the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives. Cancer Lett 2, 319-322.
84. Jornot I & Junod AF (1997) Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism. Biochem J 326, 117-123.
85. Kabuto M, Imai H, Yonezawa, C, et al. (1994) Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomarkers Prev 13, 465-469.
86. Kaeck M, Lu J, Strange R, Ip C & Ganther HE (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol 53, 921-926.
87. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW & Stotzky G (1994) Supplementation of selenium and human immune cell functions II. Effect on cytoxic lymphocytes and natural killer cells. Biol Trace Elem Res 41, 115-126.
88. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW & Stotzky G (1996) Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells. Biol Trace Elem Res 52, 227-239.
89. Klein EA, Thompson LM, Lippman SM, et al. (2001) SELECT: The next prostate cancer prevention trial. J Urol 166, 1311-1315.
90. Kok FJ, De Bruijn AM, Hofman A, Vermeeren R & Valkenburg HA (1987) Is serum selenium a risk factor for cancer in men only? Am J Epidemiol 125, 12-16.
91. Koller LD, Exon JH, Talcott PA, Osborne CA & Henningsen GM (1986) Immune responses in rats supplemented with selenium. Clin Exp Immunol 63, 570-576.
92. Kryukov GV, Castellano S, Novoselov SV, et al. (2003) Characterization of mammalian selenoproteins. Sciences 300, 1439-1443.
93. Kumar S & Holmgren A (1999) Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis 20, 1761-1767.
94. Kumaraswamy E, Malykh A, Korothov KV, et al. (2000) Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 275, 35540-35547.
95. Kumaraswamy E, Carlson BA & Morgan F (2003) Selective removal of the selenocysteine tRNA [Ser] Sec gene (Trsp) in mouse mammary epithelium. Mol Cell Biol 23, 1477-1488.
96. Lane HW & Medina D (1985) Mode of action of selenium inhibition of 7,12-demethylobenz(a)-induced mouse mammary tumorigenesis. J Natl Cancer Inst 75, 675-679.
97. Lanfear J, Flemming JJ, Wu L, Webster G & Harrison PR (1994) The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium? Carcinogenesis 15, 1387-1392.
98. Lo Boeuf RA & Hoekstra WG (1983) Adaptive changes in hepatic glutathione metabolism in response to excess dietary selenium. J Nutr 113, 845-854.
99. Li JY, Taylor PR, Li B, et al. (1993) Nutrition intervention trials in Linxian, China. J Natl Cancer Inst 85, 1492-1498.
100. Liu J, Gilbert K, Parker H, Haschek W & Milner JA (1991) Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite. Cancer Res 51, 4613-4617.
101. Lu J (2000) Apoptosis and angiogenesis in cancer prevention by selenium. In Nutrition and Cancer Prevention, pp. 131-145 New York: Kluwer Academic/Plenum Publishers, [edited under the auspices of AICR].
102. Lu J & Jiang C (2001) Antiangiogenic activity of selenium in cancer chemoprevention: Metabolite-specific effects. Nutr Cancer 40, 64-73.
103. Lu J, Jiang C, Kaech M, Ganther HE, Ip C & Thompson H (1995) Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell cultured model. Carcinogenesis, 16, 513-516.
104. Mansell JB & Berry MJ (2001) Towards a mechanism for seleno-cysteine incorporation in eukaryotes. In Selenium: Its Molecular Biology and Role in Human Health, pp. 69-81 [DL Hatfield, editor]. Boston, MA: Kluwer Academic Publishers.
105. Mark SD, Qia Y-L, Dawsey SM, et al. (2000) Prospective study of serum selenium levels and incident of esophageal and gastric cancers. J Natl Cancer Inst 92, 1753-1763.
106. Martin SE & Schillaci M (1984) Inhibitory effects of selenium on mutagenicity. J Agric Food Chem 32, 426-433.
107. Medina D & Morrison DG (1998) Current ideas on selenium as a chemopreventive agent. Pathol Immunopathol Res 7, 187-199.
108. Milner JA (1985) Effect of selenium on virally induced and transplanted tumor models. Fed Proc 44, 2568-2572.
109. Mitchell AD & Benevenga NJ (1978) The role of transamination in methionine oxidation in the rat. J Nutr 108, 67-78.
110. Navarrete M, Gaudry A, Revel G, Martinez T & Cabrera L (2001) Urinary selenium excretion in patients with cervical uterine cancer. Biol Trace Elem Res 79, 97-105.
111. Nayini J, El-Bayoumy K, Sugie S, Cohen LA & Reddy BS (1989) Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis 10, 509-512.
112. Neuhierl B, Thanbichler M, Lottspeich F & Bock A (1999) A family of S-methylmethionine-dependent thiol/selenol methyl-transferases. Role in selenium tolerance and evolutionary relation. J Biol Chem 274, 5407-5414.
113. Ng BH & Anderson JW (1979) Light-dependent incorporation of selenite and sulfite into selenocysteine and cysteine by isolated pea chloroplasts. Phytochemistry 18, 573-581.
114. Nomura A, Heilbrun LK, Morris JS & Stemmermann GN (1987) Serum selenium and the risk of cancer by specific sites: Case-control analysis of prospective data. J Natl Cancer Inst 79, 103-108.
115. Noord PA, Van Collette HJ, Maas MJ & De Waard F (1987) Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16, 318-322.
116. Oldfield JE (1999) Selenium World Atlas, pp. 83. Grimbergen: Selenium-Tellurium Development Association.
117. Olson OE, Novacek EJ, Whitehead EI & Palmer IS (1970) Investigation of selenium in wheat. Phytochemistry 9, 1181-1188.
118. Olson OE & Palmer IS (1976) Selenoamino acids in tissues of rats administered inorganic selenium. Metabolism 25, 299-306.
119. Olsson U, Onfelt A & Beije B (1984) Dietary selenium deficiency causes decreased N-oxygenation of N,N-diethylaniline and increased mutagenicity of dimethylnitrosamine in the isolated rat liver/cell culture system. Mutat Res 126, 73-80.
120. Peatrie HT, Klassen LW, Klassen PS, O'Dell JR & Kay HD (1989) Selenium and the immune response. 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo. J Leukoc Biol 45, 215-220.
121. Pence BC, Pelier E & Dunn CG (1994) Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol 102, 759-761.
122. Pence BC, Stewart M, Walsh L & Cameron G (1996) Modulation of oxidative damage in DNA by sodium selenite via the mechanism of apoptosis. In Proceedings of the 6th International Symposium on Selenium in Biology and Medicine, pp. 82-88. New York, NY: Van Nostrand Reinhold.
123. Perchellet JP, Abney NL, Thomas RM, Guislan YL & Perchellet EM (1987) Effects of combined treatments with selenium, glutathione and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction and complete and multistage carcinogenesis in mouse skin. Cancer Res 47, 477-485.
124. Poirier KA & Milner JA (1983) Factors influencing the antitumorigenic properties of selenium in mice. J Nutr 113, 2147-2154.
125. Prasad MP, Mukunda MA & Krishnaswamy K (1995) Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity. Eur J Cancer 31B, 155-159.
126. Rao L, Puschner B & Prolla TA (2001) Gene expression profiling of low selenium status in the mouse intestine: Transcriptional activation of genes linked to DNA damage, cell cycle control and oxidative stress. J Nutr 131, 3175-3181.
127. Rayman MP (2000) The importance of selenium in human health. Lancet 356, 233-241.
128. Rogers MA, Thomas DB, Davis S, Weiss NS, Vaughan TL & Nevissi AL (1991) A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue. Int J Cancer Res 48, 182-188.
129. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW & Stotzky G (1994) Supplementation with selenium and human immune cell functions. 1. Effect of lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 41, 103-113.
130. Russo MW, Murray SC, Wurzelmann JI, Woosley JT & Sandler SR (1997) Plasma selenium and the risk of colorectal adenomas. Nutr Cancer 28, 125-129.
131. Safer B, Jagaus B & Crouch D (1980) Indirect inactivation of eukaryotic initiation factor 2 in reticulocyte lysates by selenite. J Biol Chem 2545, 6913-6917.
132. Salonen JT, Alfthan G, Huttunen JK & Puska P (1984) Association between serum selenium and the risk of cancer. Am J Epidemiol 120, 342-349.
133. Schrauzer GN (2000) Anticarcinogenic effects of selenium. Cell Mol Life Sci 57, 1864-1874.
134. Schrauzer GN, White DA & Schneider CJ (1977) Mortality correlation studies. III. Statistical association with dietary selenium intakes. Bioinorg Chem 7, 23-31.
135. Schwarz K & Foltz CM (1957) Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc 79, 3292-3293.
136. Seo YR, Kelley MR & Smith ML (2002a) Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci 99, 14548-14553.
137. Seo YR, Sweeney C & Smith ML (2002b) Selenomethione induction of DNA repair response in human fibroblasts. Oncogene 21, 3663-3669.
138. Shamberger RJ (1970) Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J Natl Cancer Inst 44, 931-936.
139. Shamberger RJ & Frost DV (1969) Possible protective effect of selenium against human cancer. Can Med Assoc J 104, 82-84.
140. Shamberger RJ & Willis CE (1971) Selenium distribution of human cancer mortality. CRC Crit Rev Clin Lab Sci 2, 211-219.
141. Sinha R, Kiley SC, Ju JX, et al. (1999a) Effects of methylselenocysteine on PKC, edk 2 phosphorylation and gad gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett 146, 135-145.
142. Sinha RS, Kiley C, Ju JX, et al. (1999b) Effects of methylselenocysteine on PKC, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett 146, 135-145.
143. Smith-Rose RL (1926) Mr. J. L. Baird. Nature 158, 88-89.
144. Taylor EW (1995) Selenium and cellular immunity. Evidence that selenoproteins may be coded in the +1 reading frame overlapping the human CD4, CD8 and HLA-DR genes. Biol Trace Elem Res 49, 85-95.
145. Taylor PR, Li B, Dawsey SM, et al. (1994) Prevention of esophageal cancer: The nutrition intervention trials in Linxian, China. Cancer Res 54, 2029s-2031s.
146. Teel RW & Kain RS (1984) Selenium modified mutagenicity and metabolism of benzo(a)pyrene in anS9-dependent system. Mutat Res 127, 9-14.
147. Terry N, Zayed AM, DeSouza MP & Tarun AS (2000) Selenium in higher plants. Annu Rev Plant Physiol 51, 401-432.
148. Toma S, Micheletti A, Giacchero A, et al. (1991) Selenium therapy in patients with precancerous and malignant oral cavity lesions; Preliminary results. Cancer Detect Prev 15, 491-494.
149. Ujiie S, Itoh Y & Kukuchi H (1988) Serum selenium contents and the risk of cancer. Gan To Kogaku Ryoho 12, 1891-1897, (translated from Japanese).
150. Unni E, Singh U, Ganther HE & Sinha R (2001) Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. Biofactors 14, 169-177.
151. van den Brandt PA, Goldbohm RA, Van't Veer P, Bode P & Dorant E (1993a) A prospective cohort study on selenium status and risk of lung cancer. Cancer Res 53, 4860-4869.
152. Van Den Brandt PA, Goldbohm RA, Van't Veer P, et al. (1993b) A prospective cohort study of toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 85, 224-229.
153. Van't Veer P, Van Der Wielen RP, Kok FJ, Hermus RJ & Sturmans F (1990) Selenium in diet, blood, and toenails in relation to breast cancer: A case control study. Am J Epidemiol 131, 987-994.
154. Vernie LN, Hamburg CJ & Bont WS (1981) Inhibition of the growth of malignant mouse lymphoid cells by selenodiglutathione and selenocystine. Cancer Lett 14, 303-308.
155. Wang Z, Jiang C, Ganther HE & Lu J (2001) Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res 61, 7171-7178.
156. Waschulewski IH & Sunde RA (1988) Effect of dietary methionine on utilization of tissue selenium from dietary selenomethionine for glutathione peroxidase in the rat. J Nutr 118, 367-374.
157. Whanger PD (1989) Selenocompounds in plants and their effects on animals. In Toxicants of Plant Origin, Vol. III, Proteins and Amino Acids, pp. 141-167 [PR Cheeke, editor]. Boca Raton, FL: CRC Press.
158. Whanger PD (1992) Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. J Trace Elem Electrolytes Health Dis 6, 209-221.
159. Whanger PD (2002) Selenocompounds in plants and animals and their biological significance. J Am Coll Nutr 21, 223-232.
160. Whanger PD (2003) Metabolic pathways of selenium in plants and animals and their nutritional significance. In Nutritional Biotechnology in the Feed and Food Industries, pp. 51-58 [TP Lyons and KA Jacques, editors]. Proceedings of Allteck's 19th Annual Symposium Nottingham: Nottingham University Press.
161. Whanger PD & Butler JA (1988) Effects of various dietary levels of selenium as selenite or selenomethionine on tissue selenium levels and glutathione peroxidase activity in rats. J Nutr 118, 846-852.
162. Whanger PD, Ip C, Polan CE, Uden PC & Wilbaum G (2000) Tumorigenesis, metabolism, speciation, bioavailability and tissue deposition of selenium in selenium-enriched ramps (Allium tricoccum). J Agric Food Chem 48, 5723-5730.
163. Willett WC, Polk BF, Morris JS, et al. (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2, 130-134.
164. Yang G & Zhou R (1994) Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis 8, 159-165.
165. Yang GQ, Yin S, Zhou R, et al. (1989a) Studies on safe maximal daily dietary Se-intake in a seleniferous area in China, Part I. Relationships between selenium intake and tissue levels. J Trace Elem Electrolytes Health Dis 3, 77-87.
166. Yang GQ, Yin S & Zhou R, et al. (1989b) Studies of safe maximal daily dietary intake in a seleniferous area in China. Part II. Relation between selenium intake and manifestations of clinical signs and certain biological alterations. J Trace Elem Eletrolytes Health Dis 3, 123-130.
167. Yasumoto K, Iwami K & Yoshida M (1984) Nutritional efficiency and chemical form of selenium, an essential trace element, contained in soybean protein. Se-Te Abstr. 25, 73150.
168. Yoshizawa K, Willett WC, Morris SJ, et al. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90, 219-1224.
169. Youn BW, Fiala ES & Sohn OS (2001) Mechanisms of organoselenium compounds in chemoprevention: Effects of transcription factor-DNA binding. Nutr Cancer 40, 28-33.
170. Yu Sh-Y, Li W-G, Zhu Y-J, Yu WP & Hou C (1989) Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Elem Res 20, 15-22.
171. Yu Sh-Y, Zhu Y-J, Huang Q-S, Zhi-Huang C & Zhang QN (1991) A preliminary report of the intervention trials of primary liver cancer in high risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29, 289-294.
172. Yu Sh-Y, Zhu YJ & Li WG (1997) Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 56, 117-124.
173. Yu SY, Chu YJ, Gong XL, et al. (1985) Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol Trace Elem Res 7, 21-29.
174. Zhong W & Oberley TD (2001) Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61, 7071-7078.